Literature DB >> 23278962

Changes in the fetal and neonatal cytokine profile in pregnancies complicated by fetal growth restriction.

Edward Mullins1, Tomas Prior, Irene Roberts, Sailesh Kumar.   

Abstract

Fetal growth restriction (FGR) is a major complication of pregnancy with unknown etiology which results in marked fetal, neonatal and long-term morbidity, and mortality. FGR is likely to result from suboptimal placental implantation and perturbed immunological interactions. The diagnostic criteria for FGR vary between studies and the condition often occurs with pre-eclampsia. Here, we review published studies of fetal and neonatal cytokines in FGR and compare these with studies of small for gestational age, pre-eclampsia and pregnancies delivering pre-term.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23278962     DOI: 10.1111/aji.12052

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  4 in total

1.  The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.

Authors:  Yan Dai; Jun Zhang; Rong Liu; Na Xu; Song-Biao Yan; Yi Chen; Tian-He Li
Journal:  J Assist Reprod Genet       Date:  2020-03-25       Impact factor: 3.412

2.  Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation.

Authors:  Kevin P Robb; Tiziana Cotechini; Camille Allaire; Arissa Sperou; Charles H Graham
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

3.  A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers.

Authors:  Samantha C Lean; Rebecca L Jones; Stephen A Roberts; Alexander E P Heazell
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-20       Impact factor: 3.007

Review 4.  Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate.

Authors:  Francesca Cirillo; Pietro Lazzeroni; Chiara Sartori; Maria Elisabeth Street
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.